Mobile Phase B

Organization name

SHIMADZU CHEMISTRY AND DIAGNOSTICS

SRN

FR-MF-000048960

Manufacturer status

Active

1 warning recorded — scroll inside the panel to see all entries.

• CW010

  EUDAMED did not publish a description for this code.

Primary placement in France; available across 5 countries total.

Trade name

Mobile Phase B

UDI-DI code

03770029302030

Basic UDI-DI

3770029302IMK00TU

Reference / catalog number

227-40103-55

Issuing entity

GS1

Risk category

IVDR Class C

Applicable legislation

IVDR [Regulation (EU) 2017/746 on in vitro diagnostic medical devices]

Status

On the market

Quantity

1

Additional product description

DOSIMMUNE is a reagent suite for quantification by LC-MS/MS of the concentration of Cyclosporin A, Everolimus, Sirolimus and Tacrolimus in whole blood specimens from patients undergoing treatment with immunosuppressants. DOSIMMUNE Mobile Phase B is a constitutive component of DOSIMMUNE Reagent suite, which function is to elute the target molecules from the trapping and analytical columns to the mass spectrometry detector, where it promotes ionization.

Additional information URL

https://www.schd-shimadzu.com/

Clinical sizes

No clinical sizes registered for this device.

• W0102080699IMMUNOSUPPRESSANT TDM - OTHER

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification